Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes.
- 1 March 2010
- journal article
- Vol. 1 (1), e0110
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesThe New England Journal of Medicine, 2005
- Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetesEuropean Journal of Internal Medicine, 2004
- Special Management of Insulin Lispro in Continuous Subcutaneous Insulin Infusion in Young Diabetic Children: A Randomized Cross-Over StudyHormone Research in Paediatrics, 2004
- Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitusDiabetic Medicine, 2003
- Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes MellitusThe New England Journal of Medicine, 2003
- Insulin aspart vs. human insulin in the management of long‐term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trialDiabetic Medicine, 2000
- Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group.Diabetes Care, 1999
- Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro Mix25 and insulin lispro Mix50Clinical Therapeutics, 1999
- Reduced Frequency of Severe Hypoglycemia and Coma in Well-Controlled IDDM Patients Treated With Insulin LisproDiabetes Care, 1997
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993